Skip to main content

Lynn Briscoe

NIH Rank #2
  • Top 1% Funded
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 79478801Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2025

Linked Award Amount
$129M
Full award amounts, FY2025
Award Records
40
Records listing this PI
Award-Linked Rank
#2
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Lynn Briscoe. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Lynn Briscoe as a PI. Multi-PI records show the full award amount for context.

+30 more grants not shown.

Award organization

Organizations that administered FY2025 awards listing Lynn Briscoe as a PI.

FY2025 award administered by Leidos Biomedical Research, Inc. (MD).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Leidos Biomedical Research, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    $25M Cumulative Funding
  8. 2024
    $50M Cumulative Funding
  9. 2024
    $100M Cumulative Funding
  10. 2024
    Entered Top 50% Nationally
    Ranked #1
  11. 2024
    Entered Top 25% Nationally
    Ranked #1
  12. 2024
    Entered Top 10% Nationally
    Ranked #1
  13. 2024
    Entered Top 5% Nationally
    Ranked #1
  14. 2024
    Entered Top 1% Nationally
    Ranked #1